Mission Therapeutics’ leadership team has a wealth of international, commercial and scientific experience.

Dr Anker Lundemose

Chief Executive Officer

Anker Lundemose, MD, PhD, DMSc in Medical Microbiology, has extensive experience from business and corporate development as well as R&D in key therapeutic areas including oncology, diabetes and anti-infectives…


David Luther

Chief Financial Officer

David Luther brings more than 25 years’ financial and operational experience across the healthcare, FMCG and pharmaceutical industries. He joins Mission from Spotless Group, a private equity backed FMCG business…


Dr Paul Wallace

Chief Business Officer

Paul Wallace, PhD has 20 years’ international business development experience including both strategic and operational leadership. Most recently, he was EVP and Head of Business Development for Medivir AB…


Professor Steve Jackson

Chief Scientific Officer

After graduating in biochemistry from the University of Leeds followed by a PhD from Edinburgh University, Steve carried out post-doctoral training in the lab of Professor Robert Tjian at Berkeley, USA. In 1991, he became a…


Dr Michael Koslowski

Chief Medical Officer & EVP Research & Development

Michael Koslowski brings over 15 years’ experience across biopharmaceutical research and development, specialising in drug target discovery and clinical validation. Most recently, he was at Glenmark…